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26Objective:We have developed a prosthesis that includes a collagen layer for tracheobronchial reconstruction and
applied it in a canine model. In previous studies luminal epithelization remained partial or rather slow because of
the early disintegration of the collagen layer. We have improved this type of prosthesis by coating the luminal
surface with a biodegradable polymer, which serves to protect the collagen layer. The effect of the polymer coat-
ing on the epithelization of the luminal surface of the prosthesis was examined.
Methods: The main frame consisted of a polypropylene mesh tube, measuring 15 mm in inner diameter and 30
mm in length, with reinforcing rings. Collagen extracted from porcine skin was conjugated to this frame. The
luminal surface was coated with a polymer, poly (L-lactic-acid-co-e-caprolactone). In 5 beagle dogs the left
main bronchus was replaced with this prosthesis, periodic bronchoscopic observations were conducted, and mi-
croscopic evaluations were performed.
Results: All dogs survived until they were killed, except for 1 animal in which pneumonia developed, and this
animal died at 13 months after replacement. None of the dogs showed adverse complications caused by the pros-
thesis. Bronchoscopic observations revealed that the polymer remained on the luminal surface for 2 weeks. The
luminal surface in 4 dogs was completely covered with ciliated columnar epithelium or nonciliated squamous
epithelium, and 90% epithelization was achieved in 1 dog.
Conclusions: The biodegradable polymer coating protected the collagen layer and promoted better epitheliza-
tion. This improved epithelization on the luminal surface could therefore potentially increase the success rates
in airway replacement with artificial prostheses. (J Thorac Cardiovasc Surg 2010;139:26-31)Langer and Vacanti1 proclaimed the glorious future of tissue
engineering in their review in Science in 1993. Since then,
numerous attempts have been made to regenerate the whole
trachea, including the cartilage. Kojima and colleagues2 suc-
cessfully created a tissue-engineered trachea with cartilage
regenerated from bone marrow cells. Another attempt has
been made to regenerate the tracheal cartilage by supplying
growth factors. Igai and associates3 applied gelatin sponges,
which were designed to release basic fibroblast growth fac-
tor, into a tracheal defect and observed cartilage regenera-
tion. However, the implantation of such tissue-engineered
prostheses has been associated with a poor functional out-
come4 or only partial tissue regeneration,5 and thus its appli-
cation seems problematic. A polypropylene-framed airway
prosthesis conjugated with a collagen layer was developede Department of Bioartificial Organsa and Medical Simulation Engineering,d
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The Journal of Thoracic and Cardiovascular Surgebased on the concept of in situ tissue engineering because re-
generating a whole trachea with cartilage remains question-
able in terms of durability. The goal of in situ tissue
engineering is to create a local environment with a prepared
scaffold suitable for tissue or organ restoration.6 Collagen is
a major component of the extracellular matrix and is known
to play active roles in the migration and proliferation of cells.
We have designed a prosthesis conjugated with a lyophilized
collagen layer to act as a 3-dimensional scaffold and applied
it for regeneration of various tissues and organs, including
the gastrointestinal tract and peripheral nerves.7-9
Previous studies with this type of prosthesis have reported
the replacement of the intrathoracic trachea10,11 the carinal
part of the trachea,12 the left main bronchus in a canine
model,13 and the cervical trachea in human subjects.14 Pre-
vious attempts to replace the airway with this type of pros-
thesis revealed that the epithelization was either rather
slow or incomplete in some cases. The collagen layer possi-
bly disintegrate before host tissue regeneration, and we hy-
pothesized that the collagen layer should be isolated from
the luminal space interface and protected against early disin-
tegration for a certain period to achieve better results.
Therefore an improved prosthesis was designed, in which
the luminal surface was coated with a biodegradable poly-
mer, poly (L-lactic acid-co-e-caprolactone [L–C copoly-
mer]). L–C copolymer has been applied clinically asry c January 2010
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L–C copolymer ¼ poly (L-lactic acid-co-
e-caprolactone)artificial dura mater material. It is able to seal dura mater de-
fects and reduces the risk of intracranial hypotension.15
Sakuma and coworkers16 showed that this polymer sheet
was applicable as a substitute for the pericardium in an
experimental animal model.
The objective of the present study was to clarify whether
this type of prosthesis could be applicable for the replace-
ment of the left main bronchus in dogs and produce better
results in terms of luminal epithelization.
MATERIALS AND METHODS
Bronchial Prosthesis
The collagen-conjugated bronchial prosthesis wasmade by using amethod
similar to that described in a previous report.17 The prosthesis consists of
a framework and a collagen layer. The framework is a fine polypropylene
mesh (Marlex mesh; CR Bard, Inc, Billerica, Mass) cylinder, 30 mm long
with an internal diameter of 15 mm, reinforced with 5 rings of polypropylene
monofilament string (1 mm in diameter). This cylindrical mesh framework
was exposed to a corona discharge at 9 kV for 5 minutes to render its surface
hydrophilic. The framework was then placed in a mold, and 2% collagen so-
lution (Nippon Meat Packers, Inc, Osaka, Japan) was poured into the mold,
followed by freeze-drying to form a collagen layer 5 mm thick around the
frame and 2 mm thick from the luminal surface. The prosthesis was heated
at 140C under vacuum pressure for a 24-hour session of dehydrothermal
treatment to induce moderate cross-linkage of the collagen molecules. The
L–C copolymer (50:50 mol%; molecular weight 220,000 d) was prepared
bymeans of conventional ring–open polymerization, according to the method
reported by Nakamura and colleagues.18 The copolymer solution in 1,4-diox-
ane was spread onto the luminal surface of the prosthesis twice, followed by
overnight drying in a draft chamber. Finally, the prosthesis was sterilized with
ethylene oxide gas and stored in a desiccator until use. The schematic and
cross-sectional views of the prosthesis are shown in Figure 1.
Animal Experiment
Five adult beagle dogs weighing 8 to 14 kg were anesthetized with an
intramuscular administration of 15 mg/kg ketamine hydrochloride and 7
mg/kg xylazine and then intubated with an endotracheal tube. Respiration
was maintained by using a mechanical ventilator with halothane and nitrous
oxide gas. The procedures used for replacement of the left main bronchus
were similar to those of a previous study.19 Briefly, after the left main bron-
chus was exposed through the pulmonary–aortic window, a 10-mm segment
of the left main bronchus was resected, and the prosthesis was interposed.
Both ends of the prosthesis were anastomosed in a telescoped manner
with interrupted 3–0 Vicryl sutures (Ethicon, Inc, Somerville, NJ), with
the bronchial ends lying inside the prosthesis.
The dogs were appropriately hydrated with extracellular fluid, and 125
mg of hydrocortisone was administered during the operation. Ampicillin
was administered intravenously at a dose of 1 g on the day of the operation
and at 0.5 g daily for 3 days thereafter. Hydrocortisone (125mg) was admin-
istered intravenously for 3 days after the procedure. All of the animals re-
ceived humane care in compliance with the ‘‘Guide for the care and use
of laboratory animals’’ prepared by the Institute of Laboratory Animal Re-
sources, National Research Council, and published by the National Acad-
emy Press, revised 1996.The Journal of Thoracic and CBronchoscopic Observation
Bronchoscopic observation was done after achievement of general anes-
thesia induced with an intramuscular injection of ketamine hydrochloride
and xylazine hydrochloride. The condition of the prosthesis after implanta-
tion was evaluated with a bronchofiberscope (Model BF1T20; Olympus
Optical Co, Ltd, Tokyo, Japan) periodically at 1, 2, and 3 weeks; 1 month;
and every 2 months after implantation.
Evaluation of the Prosthesis
The replaced portion was examined bronchoscopically (Figure 2) and
macroscopically after autopsy (Figure 3). Euthanasia was performed with
an intravenous injection of 100 mg/kg ketamine hydrochloride, followed
by an autopsy.
Stenosis was defined as a reduction of more than one third of the tracheal
lumen cross-sectional area. The state of epithelization was evaluated bron-
choscopically and macroscopically to determine whether the mesh under-
neath the epithelium was exposed. Immediately after macroscopic
evaluation, the specimens were placed in 10% formaldehyde solution, fol-
lowed by paraffin embedding. Five-micrometer sections were cut and
stained with hematoxylin and eosin for light microscopy.RESULTS
The outcome of the experiments is shown in Table 1. All
the dogs survived the postoperative period without any ap-
parent morbidity. One dog died of pneumonia at 13 months
after bronchial replacement. This dog showed no dehiscence
of the anastomosis or infection of the prosthesis during the
postoperative period until pneumonia developed.Bronchoscopic and Macroscopic Examination
Neither stenosis nor excessive granulation was observed
in this series of dogs.
The inner lumen was fully covered in 4 dogs, and in 1 dog
90% of the luminal surface was judged to be covered by the
epithelium.
Periodic bronchoscopy revealed that the L–C copolymer
layer remained on the collagen layer for up to 2 weeks (Table
1). One week after replacement, the copolymer layer ap-
peared to remain over the entire length, except in 1 dog.
Two weeks after the replacement, in 4 dogs the copolymer
layer had disappeared, whereas in 1 dog the copolymer layer
partially remained. Bronchoscopic observations at 1 month
after implantation confirmed that the polymer layer and the
collagen layer had been replaced by regenerated tissue
(Figure 2).
The host tissue incorporated the framework of the pros-
thesis, and neither erosion nor dehiscence was observed
between the framework and the adjacent vessels. No compli-
cations, such as hemoptysis or intrathoracic hemorrhage,
were observed.Histologic Findings
A regenerated ciliated columnar epithelium was ob-
served macroscopically. Near the center of the prosthesis,
the proportion of squamous epithelium became larger
than that of ciliated columnar epithelium (Figure 3, Bardiovascular Surgery c Volume 139, Number 1 27
FIGURE 1. A, The bulk structure of the prosthesis framework: a mesh cylinder reinforced with 5 rings of polypropylene string. B, Cross-sectional schema of
the prosthesis conjugated with a collagen layer. The L-lactic acid-co-e-caprolactam (L–C copolymer) layer is colored blue.
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Sand C). No residual copolymer layer was observed on the
resected specimen. No immigration of inflammatory cells
was evident under the regenerated epithelium, indicatingFIGURE 2. Periodical bronchoscopic views of the replaced portion after trache
colored copolymer layer. At day 7, the copolymer coating remained. At day 14, r
apparently disappeared. At day 21, the luminal surface was covered with whitish
epithelium. At day 180, neomucosae with regenerated blood vessels were obser
28 The Journal of Thoracic and Cardiovascular Surgethat the prosthesis was well incorporated without any ex-
cessive foreign-body reaction attributable to the copolymer
or collagen.al replacement. At day 0, the replaced portion can be identified by the blue-
egenerated reddish tissue could be observed, and the copolymer coating had
tissue. At day 30, the luminal surface was completely covered with a smooth
ved (arrows).
ry c January 2010
FIGURE 3. A, Macroscopic view of the luminal surface of the prosthesis 18 months after implantation. The arrow shows the regenerated part. The luminal
surface is covered with apparently normal mucosa. B, Microscopic examination of a longitudinal section of the regenerated tissue 18 months after prosthesis
implantation. The regenerated neomucosa with an epithelial lining is observed on the prosthesis. (Hematoxylin and eosin staining, magnification 103.) C,
Ciliated columnar epithelial cells have grown over the prosthesis, whereas the center of the prosthesis is not as dense as in the peripheral regions. (Hematoxylin
and eosin staining, magnification 403.) L, Bronchial lumen; P, polypropylene mesh.
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SDISCUSSION
A multilayered-type collagen-conjugated prosthesis con-
sisting of collagen and a biodegradable L–C copolymer
layer was used to replace the canine left main bronchus.
This is the first trial in which L–C copolymer was applied
in a tissue-engineered airway replacement. In contrast with
the previous studies using a collagen-monolayered prosthe-
sis, good results were achieved in terms of epithelization.
Together with major advances in surgical techniques that
now enable rather complex forms of bronchoplasty20,21 and
reconstruction of tracheal defects more than 6 cm long,22
the risk of potentially fatal complications, such as local infec-
tion, stenosis, or rupture of the adjacent vessels,23-25 still pre-
cludes the clinical use of artificial prostheses in this situation.
However, because reconstruction of the trachea involving
lengthy resections exceeding 4 cm is associated with a high
morbidity rate,26 there is a clinical demand for an appropriate
prosthesis that can avoid any stretching stress at the anasto-
mosis site. We consider that the conditions required for an
ideal prosthesis are (1) adequate durability tomaintain a func-
tional airway after implantation, (2) relatively low cost, andTABLE 1. Results of replacement of the left main bronchus
Dog Stenosis Epithelization
State of poly
coating at da
1 () 90% Full
2 () 100% Partial
3 () 100% Full
4 () 100% Full
5 () 100% Full
The Journal of Thoracic and C(3) high biocompatibility, thus enabling incorporation into
the host tissue. A tissue-engineered collagen-conjugated
prosthesis that potentially meets these requirements was
investigated. This type of prosthesis is equipped with a poly-
propylene framework as a substitute for cartilage, which is
sufficiently stable to maintain the lumen long after transplan-
tation.Animal experiments have shown that this type of pros-
thesis has appropriate mechanical properties similar to those
of the native trachea.27 Observations of a canine tracheal re-
placement model for more than 5 years has proved that it is
durable and free from potentially fatal problems, such as
anastomotic leakage or postanastomotic stenosis.28 Clini-
cally, Omori and colleagues29 have applied this tissue-engi-
neered tracheal prosthesis to the cervical trachea of 8 human
patients to date, with amaximum follow-up period of 4 years.
This type of prosthesis is suitable for commercial produc-
tion in various sizes and lengths at relatively low cost in
comparison with biologic transplant grafts and is free from
any risk of donor-related infection.
A prosthesis with a foam-type collagen layer results in bet-
ter tissue incorporation than a prosthesis with an amorphousmer
y 7
State of polymer
coating at day 14 Remarks
Partial Killed at 18 mo
Disappeared Pneumonia leading
to death at 13 months
Disappeared Killed at 18 mo
Disappeared Killed at 17 mo
Disappeared Killed at 17 mo
ardiovascular Surgery c Volume 139, Number 1 29
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Scollagen monolayer coat.10,12,17 These results indicate that
a collagen layer with a 3-dimensional structure potentially
provides an appropriate extracellular matrix in which migrat-
ing cells can proliferate, thus enhancing tissue regeneration.
Despite these favorable characteristics, the collagen layer
is quite fragile and tends to detach either during the surgical
procedure or after implantation. A silicone tube has been set
inside the prosthesis and then extracted 8 weeks after im-
plantation to protect the collagen layer. This procedure pre-
vented the early degradation of the collagen layer and
allowed complete coverage of the prosthesis framework in
90% of cases.11,12
In a previous trial of left main bronchus replacement,13 no
protectant was applied for the collagen layer because the sil-
icone tube insertion and removal were rather complicated
procedures and might cause serious problems. However,
complete epithelization was achieved in only 2 of 8 cases.
Based on these observations, a biodegradable polymer
was applied to the luminal surface of the prosthesis to protect
the collagen layer. The L–C copolymer consists of 2 ele-
ments: poly-L-lactic acid is rather firm and degrades slowly,
and copolymerization with e-caprolactone makes the poly-
mer markedly elastic. The copolymer is designed to disinte-
grate in about 10 to 20 days, during which time it provides
appropriate mechanical support. In the preparation of the
prosthesis, the L–C copolymer solution was spread on its lu-
minal surface to create an additional layer. This additional
polymer layer was able to effectively keep the prosthesis air-
tight, while also improving its mechanical strength during
the implantation procedures. No adverse effects, such as ex-
cessive granulation formation or infection, were observed
after implantation.
Bronchoscopic observations confirmed that the polymer
layer remained at the local site and protected the collagen
layer for 7 to 14 days after implantation. The luminal surface
was completely covered with epithelium, containing ciliated
columnar and squamous epithelium, in 4 of 5 dogs. These
results showed a stark contrast to the previous poor outcome
in terms of epithelization.13 These results suggest that it is
important to separate the collagen layer from the luminal in-
terface for 2 weeks to avoid any early disintegration. During
this period, the collagen scaffold possibly provides an envi-
ronment to form subepithelial tissue appropriate for the sub-
sequent epithelization. Clinical experience has demonstrated
that a partial replacement of the cervical trachea without
protection of the collagen layer required a rather long period
(2–22 months) to achieve complete epithelization. No
adverse events occurred before the complete epithelization;
however, rapid and complete luminal epithelization must be
achieved. Although further experiments with replacement
using a longer prosthesis are required when considering
clinical application, the observations in this study imply
that this improved type of prosthesis might allow for rapid
and complete epithelization.30 The Journal of Thoracic and Cardiovascular SurgeCONCLUSIONS
The present study showed that the biodegradable copoly-
mer poly (L-lactic acid-co-e-caprolactone) can be applied to
protect the collagen layer. The biodegradable polymer coat-
ing remained until 14 days after implantation. The protection
of the collagen layer is important to promote better epitheli-
zation on the luminal surface of the artificial bronchial pros-
thesis in this canine model.
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